Related references
Note: Only part of the references are listed.Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
Robert J. Mentz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials
Peter S. Pang et al.
AMERICAN HEART JOURNAL (2011)
Beyond dyspnoea as an endpoint in acute heart failure trials
Mihai Gheorghiade et al.
EUROPEAN HEART JOURNAL (2011)
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study
Marco Metra et al.
EUROPEAN HEART JOURNAL (2011)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
C. M. O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A review of dyspnea in acute heart failure syndromes
Ryenn L. West et al.
AMERICAN HEART JOURNAL (2010)
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study
Alexandre Mebazaa et al.
EUROPEAN HEART JOURNAL (2010)
Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review
Miriam J. Johnson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study
Marco Metra et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
S3 Detection as a Diagnostic and Prognostic Aid in Emergency Department Patients With Acute Dyspnea
Sean P. Collins et al.
ANNALS OF EMERGENCY MEDICINE (2009)
Effects of tolvaptan on dyspnoea relief from the EVEREST trials
Peter S. Pang et al.
EUROPEAN HEART JOURNAL (2009)
Design and rationale of the URGENT Dyspnea study: An international, multicenter, prospective study
Peter S. Pang et al.
AMERICAN JOURNAL OF THERAPEUTICS (2008)
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
Peter S. Pang et al.
EUROPEAN HEART JOURNAL (2008)
Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)
Larry A. Allen et al.
JOURNAL OF CARDIAC FAILURE (2008)
Changing Preferences for Survival After Hospitalization With Advanced Heart Failure
Lynne W. Stevenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function - A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database
CW Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications - An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)
WT Abraham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Share Paper
